Phibro Animal Health (PAHC) Share-based Compensation (2018 - 2026)
Phibro Animal Health (PAHC) posted Share-based Compensation of $413000.0 for Q2 2026, down 36.51% on a QoQ basis from $650524.0 in Q1 2026, and up 130.73% year-over-year from $179000.0 in Q2 2025.
Powered by 
Analysis
Phibro Animal Health (PAHC) Share-based Compensation (2018 - 2026) Analysis & Trends
Phibro Animal Health has reported Share-based Compensation for 7 years, with the latest figure at $413000.0 in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 130.73% year-over-year to $413000.0 in Q2 2026; TTM through Jun 2026 was $951000.0, a 32.64% increase from a year earlier, with the FY2026 full-year figure at $4.4 million, down 2.47% from the prior year.
- Share-based Compensation was $413000.0 for Q2 2026 at Phibro Animal Health, down from $650524.0 in the prior quarter.
- The five-year high for Share-based Compensation was $5.1 million in Q2 2023, with the low at $80000.0 in Q4 2023.
- Average Share-based Compensation over 4 years is $699550.2, with a median of $180000.0 recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation sank 96.48% in 2024, then surged 322.22% in 2025.
- Over 4 years, Share-based Compensation stood at $80000.0 in 2023, then surged by 125.0% to $180000.0 in 2024, then soared by 278.98% to $682162.0 in 2025, then tumbled by 39.46% to $413000.0 in 2026.
- The last three Share-based Compensation figures came in at $413000.0 (Q2 2026), $650524.0 (Q1 2026), and $682162.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 16.09 Mn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 92.00 Mn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 7.00 Mn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 413,000.00 |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | 239,867.00 |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 413,000.00 |
| Mar 31, 2026 | 650,524.00 |
| Dec 31, 2025 | 682,162.00 |
| Sep 30, 2025 | 683,847.00 |
| Jun 30, 2025 | 179,000.00 |
| Mar 31, 2025 | 570,000.00 |
| Dec 31, 2024 | 180,000.00 |
| Sep 30, 2024 | 179,000.00 |
| Jun 30, 2024 | 179,000.00 |
| Mar 31, 2024 | 135,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Sep 30, 2023 | 81,000.00 |
| Jun 30, 2023 | 5.08 Mn |
| Dec 31, 2020 | 564,000.00 |
| Sep 30, 2020 | 565,000.00 |
| Jun 30, 2020 | 565,000.00 |
| Mar 31, 2020 | 565,000.00 |
| Dec 31, 2019 | 564,000.00 |
| Sep 30, 2019 | 565,000.00 |
| Jun 30, 2019 | 565,000.00 |